Trial Profile
Randomised Open Label Study of Insulin Degludec Versus Insulin Glargine U100 in Ramadan
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Insulin degludec (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 04 Jun 2020 Status changed from not yet recruiting to discontinued.
- 24 Nov 2017 New trial record